Your browser doesn't support javascript.
loading
Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma.
Sasaki, K; Uehara, J; Iinuma, S; Doi, H; Honma, M; Toki, Y; Ishida-Yamamoto, A.
Afiliação
  • Sasaki K; Department of Dermatology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan. Electronic address: kentas-canon@asahikawa-med.ac.jp.
  • Uehara J; Department of Dermatology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Iinuma S; Department of Dermatology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Doi H; Department of Dermatology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Honma M; Department of Dermatology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Toki Y; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
  • Ishida-Yamamoto A; Department of Dermatology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.
Ann Oncol ; 29(7): 1602-1603, 2018 07 01.
Article em En | MEDLINE | ID: mdl-29741568

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfo-Histiocitose Hemofagocítica / Neoplasias Pulmonares / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfo-Histiocitose Hemofagocítica / Neoplasias Pulmonares / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2018 Tipo de documento: Article